This grant supports exploratory clinical trials focused on arthritis and musculoskeletal and skin diseases under the R61 mechanism. It emphasizes simplified review processes and requires applicants to conduct clinical trials compliant with NIH standards. Eligible applicants include a broad range of U.S. institutions and organizations.
Eligible applicants include a wide range of U.S. entities such as federally recognized Native American tribal governments, state and local governments, institutions of higher education, nonprofits, small businesses, and for-profit organizations. Specific eligibility details are provided in the full
